AzTrials
AzTrials

Hallux ValgusNCT06262204

Hallux Valgus Correction Using the Metal Screw or the Human Allogeneic Cortical Bone Screw (Shark Screw).

A study testing Hallux Valgus Treatment with Shark Screw® and Hallux Valgus Treatment with metal screw in people with Hallux Valgus, run by Orthopedic Hospital Vienna Speising at 1 site in Austria.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to compare the treatment of Hallux Valgus using the conventional method (metal screw) with the new method (human allogeneic cortical bone screw (Shark Screw®) in adult patients with confirmed Hallux Valgus. Read more about this study

Who is it for?
Ages 18 to 85 years
Conditions the study is for
Hallux Valgus
What is being tested?
Hallux Valgus Treatment with Shark Screw® and Hallux Valgus Treatment with metal screw
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteAustria
Study dates
1 Dec 2026to 31 Dec 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • between 18 and 85
  • confirmed Hallux Valgus

Who cannot join

  • <18 years and >85 years
  • Known underlying oncological disease
  • Pregnant women or breastfeeding mothers
  • Alcohol and drug abuse
  • Foreseeable compliance problems
  • Foreseeable loss of responsibility as a study doctor
Show all 10Show fewer
  • Neoplastic diseases
  • Active osteomyelitis
  • Ulcerations in the area of the skin of the surgical site
  • Immunosuppressive medication that cannot be discontinued

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Florian Wenzel-Schwarz, MD contact

+43180182 ext. 3081

florian.wenzel@oss.at

Andreas Kranzl, PhD contact

Andreas.Kranzl@oss.at

Austria1 site
  • Abteilung für Kinderorthopädie und Fußchirurgie Orthopädisches Spital Speising

    Vienna, 1130

    Florian Wenzel-Schwarz, MD, +43180182 ext. 3081, florian.wenzel-schwarz@oss.at

    Florian Wenzel-Schwarz, MD

Other trials in Austria

About this study

Official title: Clinical and Radiological Comparison of Hallux Valgus Correction Using the Metal Screw or the Human Allogeneic Cortical Bone Screw, a Prospective Study

The goal of this clinical trial is to compare the treatment of Hallux Valgus using the conventional method (metal screw) with the new method (human allogeneic cortical bone screw (Shark Screw®) in adult patients with confirmed Hallux Valgus.

The main questions it aims to answer are:

Can the new method obtain comparable results as the conventional method in regard to union rate and time to union? Are the number of complications lower with the new method? Participants will be operated either with the metal screw or with the Shark Screw®. The assignment to the groups is randomized.

Read the detailed description

The planned prospective study will investigate whether the use of the human allogenic cortical bone screw (Shark Screw® leads to comparable results in the union rate and the prevention of recurrences as with metal screws. Furthermore, it will be investigated whether rotational stability is possible with the bone screw. The measurement of the HVA angle and the IMA angle should provide information on whether the correction is stable over time. A comparison of the AOFAS forefoot score before and after the operation for both methods is a further measure to check whether the human allogenic cortical bone screw can deliver similar results.

Initial studies on the use of the allogenic bone screw in hand and foot surgery show particularly good integration behavior of the human allogenic cortical bone screw . A retrospective study by Hanslik-Schnabel et al has shown initial positive results in the treatment of hallux rigidus. In addition, a gait analysis is performed pre- and postoperatively to provide information on possible differences between the two groups in the context of 3D gait analysis/pedobarography and is also matched with another healthy cohort.

At the preoperative time point and after 12 and 24 months, a 3D gait analysis with a foot model is conducted to record the joint kinematics and kinetics. In the study by Canseco et al. , the proximal gait pattern changes remained unchanged. Hwang reported hyper-external rotation in the subtalar joint, excessive eversion in the subtalar joint, and lack of movement in the hallux MP joint in the terminal standing phase.

Conditions
Hallux Valgus
Being tested
Hallux Valgus Treatment with Shark Screw®, Hallux Valgus Treatment with metal screw
Keywords
Hallux Valgus, human allogeneic cortical bone screw, Shark Screw®, HVA, IMA, AOFAS, time to union, union rate, FFI
Medical subject headings
Hallux Valgus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hallux Valgus Treatment with Shark Screw®Procedure or surgery

    This is a prospective, randomised study in which hallux valgus is corrected by means of a chevron/kin surgery technique using metal screws or human allogenic cortical bone screws (Shark Screw®, Surgebright, Lichtenberg, Austria). X-rays are taken before the operation at 6 weeks, three, six and twelve months after the operation. The X-ray images provide information on whether bony degeneration has taken place. In addition, the American Orthopaedic Foot \& Ankle Society (AOFAS) hallux score, FFI score, hallux valgus angle (HVA) and intermetatarsal angle (IMA) are determined. These data are collected preoperatively and 4 weeks (HVA and IMA), six and twelve months postoperatively in order to rule out a change in the HVA and IMA and to document the changes in the AOFAS/FFI.

  • Hallux Valgus Treatment with metal screwProcedure or surgery

    This is a prospective, randomised study in which hallux valgus is corrected by means of a chevron/kin surgery technique using metal screws or human allogenic cortical bone screws (Shark Screw®, Surgebright, Lichtenberg, Austria). X-rays are taken before the operation at 6 weeks, three, six and twelve months after the operation. The X-ray images provide information on whether bony degeneration has taken place. In addition, the American Orthopaedic Foot \& Ankle Society (AOFAS) hallux score, FFI score, hallux valgus angle (HVA) and intermetatarsal angle (IMA) are determined. These data are collected preoperatively and 4 weeks (HVA and IMA), six and twelve months postoperatively in order to rule out a change in the HVA and IMA and to document the changes in the AOFAS/FFI.

Study groups in NCT06262204
Study groupRoleWhat they receive
conventional groupOtherstandard surgery with metal screw
Receives: Procedure: Hallux Valgus Treatment with metal screw
Shark Screw® groupExperimentalnew surgical procedure with human allogeneic cortical bone screw
Receives: Procedure: Hallux Valgus Treatment with Shark Screw®

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. clinical result of Hallux Valgus treatment

    The primary objective of the study is the longitudinal evaluation of clinical outcomes (pain, appearance) over 2 years after hallux correction using a human, allogenic, bone screw or metal screw.

    Measured: 2 years

Secondary outcomes (5)
  1. radiological (bony union)result of Hallux Valgus treatment

    The secondary aim of the study is the longitudinal evaluation of the radiological results over one year after hallux correction using a human, allogenic, bone screw or metal screw compared to pre-surgery values.

    Measured: 1 years

  2. change in forefoot-American Orthopaedic Foot and Ankle Society (AOFAS)

    The change in forefoot-AOFAS will be evaluated, between groups and in comparison to pre-surgery

    Measured: 2 years

  3. Hallux-Valgus angle (HVA) change

    Comparison of HVA pre-surgery and after 6, 12 and 24 months after surgery, between groups and in comparison to pre-surgery data

    Measured: 2 years

  4. gait analysis

    Number of patients with normal gait in the two groups and in comparison to a healthy cohort

    Measured: 2 years

  5. Intermetatarsal angle (IMA) change

    Comparison of IMA pre-surgery and after 6, 12 and 24 months after surgery, between groups and in comparison to pre-surgery data

    Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Feb 2024
  2. Study start1 Dec 2026 (estimated)
  3. Primary completion31 Dec 2028 (estimated)
  4. Study completion31 Dec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06262204
Sponsor's protocol ID
Hallux Shark Screw(R)
Status last verified
Mar 2026
First submitted
29 Jan 2024
Last updated
2 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Due to sensitivity of Data

Questions about this trial

What is this clinical trial studying?

A study testing Hallux Valgus Treatment with Shark Screw® and Hallux Valgus Treatment with metal screw in people with Hallux Valgus, run by Orthopedic Hospital Vienna Speising at 1 site in Austria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 2 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Austria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Florian Wenzel-Schwarz, MD (+43180182 ext. 3081, florian.wenzel@oss.at), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

clinical result of Hallux Valgus treatment (time frame: 2 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in